OCRA has joined 71 other organizations in signing on to a letter calling for the U.S. Senate to incorporate critical reforms into the Prescription Drug User Fee Act (PDUFA) reauthorization which, if implemented, would improve diversity in clinical trials. These reforms, which are included as provisions in the U.S. House version, would make a number of … Continued
Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we asked for our community’s help in collecting signatures on a bipartisan Dear Colleague letter in the House of Representatives requesting a major funding increase to the Ovarian … Continued
We need your help today to ensure that a critical ovarian cancer research program is adequately funded. The congressional appropriations process for the 2023 fiscal year is well underway and the ovarian cancer community is requesting $50 million for the Ovarian Cancer Research Program (OCRP) at Department of Defense (DoD), a $5 million increase over current funding levels. … Continued
Update: On 3/11/22, President Biden SIGNED the FY2022 spending bill into law, implementing key ovarian cancer program increases. This represents a major win for the ovarian cancer community, and we applaud all who lent their voices to earn this victory. If you have ever lent your voice on behalf of our shared mission, you — … Continued
This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all of us at OCRA. Advocacy Patient Support & Programs Events Research Ways to Give
Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community. Only three weeks into 2022, and we already have a lot to share. So, without further ado … Research … Continued
This time of year always has us reflecting on what we’ve accomplished, what we hope to achieve in the future, and how we — with the support of the entire ovarian cancer community — can lean in even harder to our commitment of being a voice for all those touched by the disease, and finding better treatments and a … Continued
The application period has now closed. Apply today to join survivors, caregivers and activists across the country to affect change for those impacted by ovarian cancer. Advocate Leaders will learn how to educate federal and state policymakers about the disease, protect funding for lifesaving research, and fight for expanded access to treatment and care. No legislative or … Continued
As we head into the Thanksgiving holiday, we have much to be thankful for … an embracing and strong survivor community, supporters who remain ever committed to the cause, and brilliant grantees who are making strides every day in the search for better treatments and a cure for ovarian cancer. Here’s a roundup of what’s … Continued
Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Yet enrollment and widespread availability remain a challenge. To address both financial barriers and inequity in participation, OCRA is urging Congress to pass the DIVERSE (Diversifying Investigations Via Equitable Research Studies for Everyone) Trials Act (H.R. 5030/S. … Continued
Have we got a roundup in store! You heard from us a lot in September (thanks to you, we surpassed our Ovarian Cancer Awareness Month fundraising goal!) and there’s still so much to report … research progress, a brand new clinical trial initiative, our upcoming Fall Advocacy Day, and the list goes on. Read on … Continued
B. Dana Kivel has a plea to the ovarian cancer community, to medical professionals, to the world: “See me. Listen to me. I’m one of the people, the tens of thousands of people who have metastatic ovarian cancer.” But while Dana has a gendered gynecologic cancer, their gender identity does not align with what one would … Continued
Get email updates about research news, action alerts, and ways to join the fight.
